EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

The Impact of Point-of-Care Testing for Influenza on Antimicrobial Stewardship in UK Primary Care: Nested Cohort Study

Uy Hoang iD, Jessica Smylie iD, Elizabeth Button iD, Jack Macartney iD, Cecilia Okusi iD, Rachel Byford iD, Filipa Ferreira iD, Charis Xie iD, Mark Joy iD, Tristan Clark iD, Simon de Lusignan iD

JMIR Public Health and Surveillance · 2025

DOI: 10.2196/72322 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift JMIR Public Health and Surveillance, 2025. Verfasst von Uy Hoang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Primary Care Health Sciences, Medical Sciences Division, University of Oxford, Gibson Building, Radcliffe Observatory Quarter,…. Hauptthemen laut MEDLINE: Influenza, Human, Point-of-Care Testing, Antimicrobial Stewardship. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Influenza and respiratory syncytial virus (RSV) predominantly circulate during the winter season and cause acute respiratory illness (ARI). Deploying molecular point-of-care testing (POCT) in primary care can inform whether a patient presenting with an ARI has influenza or RSV. An early virological diagnosis could facilitate appropriate use of antivirals and enable better antimicrobial stewardship.

Objective

This study aimed to report the impact of POCT for influenza and RSV on antimicrobial prescribing, including antiviral therapy in primary care.

Methods

The impact of POCT for influenza on antimicrobial stewardship (PIAMS) in UK primary care was a nested cohort study undertaken from January 20 to May 31, 2023, after the period of peak virus circulation, within practices that contribute data to the English sentinel network. People presenting with ARI had a nasopharyngeal swab performed and were tested for influenza and RSV with a molecular POCT analyzer located within the practice. Data on antimicrobial prescribing and other study outcomes were collected by linking information from the analyzer to coded data from the patient’s computerized medical record.

Results

In total, 323 swabs were collected from 10 PIAMS study practices. In total, 59.7% (197/323) of swabbed patients were female, and the mean age was 37.28 (SD 25.05) years. Furthermore, 2.9% (9/323) of all swabs were positive, with 0.3% (1/323) positive for influenza A, 1.6% (5/323) positive for influenza B, and 0.9% (3/323) positive for RSV. In total, 80 patients were prescribed antibiotics 7 days following POCT testing. There were no instances of antiviral prescribing in the 7 days post testing. A statistically significant difference in antibiotic prescribing given a positive POCT result compared with a negative test was not found with an unadjusted odds ratio (OR) of 7 days post testing. A statistically significant difference in antibiotic prescribing given a positive POCT result compared with a negative test was not found with an unadjusted OR of 1.54 (95% CI 0.38‐6.30; P =.55) and adjusted OR of 1.21 (95% CI 0.00‐1.78).

Conclusions

This study illustrates the risk of having a narrow study window; our observation period was not aligned with when influenza was circulating. The peak of weekly incidence of influenza in the sentinel network was in the last week of 2022, and RSV was circulating before this. Further evidence is needed to assess the impact of POCT on antimicrobial prescribing. The viruses tested for using POCT could be aligned with the circulating viruses identified by the sentinel network.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza, HumanPoint-of-Care TestingAntimicrobial StewardshipHumansPrimary Health CareUnited KingdomFemaleMaleCohort StudiesMiddle AgedAdultAgedAdolescentChildChild, PreschoolRespiratory Syncytial Virus InfectionsAntiviral AgentsInfantYoung Adult

Stichwörter der Autor:innen

computerizedhealth careimplementationinfluenzamedical records systemsoutcome assessmentpoint of care systemsprimary care

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Nuffield Department of Primary Care Health Sciences, Medical Sciences Division, University of Oxford, Gibson Building, Radcliffe Observatory Quarter, Woodstock Road, Oxford, OX2 6GG, United Kingdom, 44 1865289344.
  • Barts and The London School of Medicine and Dentistry, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom.
  • Faculty of Medicine, School of Clinical and Experimental Sciences, University of Southampton, Southampton, United Kingdom.
  • Royal College of General Practitioners, London, United Kingdom.

ORCID-Profile: Uy Hoang, Jessica Smylie, Elizabeth Button, Jack Macartney, Cecilia Okusi, Rachel Byford, Filipa Ferreira, Charis Xie, Mark Joy, Tristan Clark, Simon de Lusignan

Zitieren

APA

Hoang, U., Smylie, J., Button, E., Macartney, J., Okusi, C., Byford, R., Ferreira, F., Xie, C., Joy, M., Clark, T., & de Lusignan, S. (2025). The Impact of Point-of-Care Testing for Influenza on Antimicrobial Stewardship in UK Primary Care: Nested Cohort Study. JMIR Public Health and Surveillance. https://doi.org/10.2196/72322

Vancouver

Hoang U, Smylie J, Button E, Macartney J, Okusi C, Byford R, et al. The Impact of Point-of-Care Testing for Influenza on Antimicrobial Stewardship in UK Primary Care: Nested Cohort Study. JMIR Public Health and Surveillance. 2025. doi:10.2196/72322

BibTeX
@article{Hoang2025,
  author = {Hoang, Uy and Smylie, Jessica and Button, Elizabeth and Macartney, Jack and Okusi, Cecilia and Byford, Rachel and Ferreira, Filipa and Xie, Charis and Joy, Mark and Clark, Tristan and de Lusignan, Simon},
  title = {The Impact of Point-of-Care Testing for Influenza on Antimicrobial Stewardship in UK Primary Care: Nested Cohort Study},
  journal = {JMIR Public Health and Surveillance},
  year = {2025},
  doi = {10.2196/72322}
}
Kostenlos starten →